Active ingredient: Each effervescent tablet contains 200 mg acetylcysteine.
Acute and chronic respiratory tract diseases accompanied by the formation of thick, difficult-to-expel mucus, such as: acute and chronic bronchitis, obstructive bronchitis, pneumonia, bronchiectasis, bronchial asthma, bronchiolitis, as well as cystic fibrosis, acute and chronic sinusitis, inflammation of the middle ear (otitis media) — secretolytic therapy.
Hypersensitivity to acetylcysteine or to any of the excipients. Active peptic ulcer. Children under 2 years of age.
Pregnancy Information about exposure of pregnant women to the effects of acetylcysteine is limited. Animal studies have not shown that it affects pregnancy, embryo/fetal development, labor, or postnatal development. Acetylcysteine may be used during pregnancy only after a careful assessment of the benefit-risk ratio. Lactation There is no information about the transfer of the product into breast milk.
Acetylcysteine may be used during lactation only after a careful assessment of the benefit-risk ratio.
Unknown.
Unless otherwise prescribed, it is recommended to take ASS in the following doses: Adults and adolescents over 14 years: 1 effervescent tablet 2–3 times daily (equivalent to 400–600 mg acetylcysteine per day). Adolescents and children from 6 to 14 years: 1 effervescent tablet twice daily (equivalent to 400 mg acetylcysteine per day). Children from 2 to 5 years: ½ effervescent tablet 2–3 times daily (equivalent to 200–300 mg acetylcysteine per day). Cystic fibrosis: Adolescents and children over 6 years: 1 effervescent tablet 3 times daily (equivalent to 600 mg acetylcysteine per day). Children from 2 to 6 years: ½ effervescent tablet 4 times daily (equivalent to 400 mg acetylcysteine per day). Method of use: Take orally after dissolving. The effervescent tablet is dissolved in a glass of drinking water and taken after meals. Fluid intake enhances the mucolytic effect of acetylcysteine. Duration of use: For short-term acute cold-related illnesses, the treatment duration is 5–7 days.
In chronic bronchitis and cystic fibrosis, the product should be taken for a longer period to achieve infection prophylaxis.
Product Filters | ||
|---|---|---|
| Supplier Product Code | : | 111-06086 |